Next Article in Journal
A Fuzzy-Based Context-Aware Misbehavior Detecting Scheme for Detecting Rogue Nodes in Vehicular Ad Hoc Network
Next Article in Special Issue
Armband Sensors Location Assessment for Left Arm-ECG Bipolar Leads Waveform Components Discovery Tendencies around the MUAC Line
Previous Article in Journal
Motorway Bottleneck Probability Estimation in Connected Vehicles Environment Using Speed Transition Matrices
Previous Article in Special Issue
Solving Inverse Electrocardiographic Mapping Using Machine Learning and Deep Learning Frameworks
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

A Systematic Review of the Transthoracic Impedance during Cardiac Defibrillation

by
Yasmine Heyer
1,*,
Daniela Baumgartner
2 and
Christian Baumgartner
1,*
1
Institute of Health Care Engineering with European Testing Center of Medical Devices, Graz University of Technology, A-8010 Graz, Austria
2
Clinical Division of Pediatric Cardiology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, A-8036 Graz, Austria
*
Authors to whom correspondence should be addressed.
Sensors 2022, 22(7), 2808; https://doi.org/10.3390/s22072808
Submission received: 27 February 2022 / Revised: 24 March 2022 / Accepted: 28 March 2022 / Published: 6 April 2022

Abstract

:
For cardiac defibrillator testing and design purposes, the range and limits of the human TTI is of high interest. Potential influencing factors regarding the electronic configurations, the electrode/tissue interface and patient characteristics were identified and analyzed. A literature survey based on 71 selected articles was used to review and assess human TTI and the influencing factors found. The human TTI extended from 12 to 212 Ω in the literature selected. Excluding outliers and pediatric measurements, the mean TTI recordings ranged from 51 to 112 Ω with an average TTI of 76.7 Ω under normal distribution. The wide range of human impedance can be attributed to 12 different influencing factors, including shock waveforms and protocols, coupling devices, electrode size and pressure, electrode position, patient age, gender, body dimensions, respiration and lung volume, blood hemoglobin saturation and different pathologies. The coupling device, electrode size and electrode pressure have the greatest influence on TTI.

1. Introduction

The most effective method of treating ventricular tachyarrhythmias is rapid termination by an electric countershock, known as defibrillation. The magnitude and the distribution of the applied current play critical roles in defibrillation and are directly related to the TTI across the capacitor discharge of the defibrillator [1,2]. By definition, the TTI indicates the resistance of the thorax to the flow of current and is measured to check whether the defibrillation electrodes are correctly attached to the patient’s thorax. This affects the current amplitude and energy and thus the success rate of defibrillation. A smaller TTI means that less energy must be delivered to the body to achieve adequate current through the heart. A smaller transthoracic current flow could help prevent myocardial cell damage, necrosis and skin burns [3]. Various experiments have shown that of the total applied current, only 4 % flows through the myocardium [4]. 82 % are shunted off by the skeletal muscle layer and 14 % by the lungs [1]. These observations highlight the need to analyze and determine the various factors that influence TTI in order to optimize the energy dosage and the current paths, and thus defibrillation outcomes. Some factors are constant and cannot be changed, such as the particular tissue impedance or chest volume [5]. However, other factors are determined by the applicant or the hardware of the defibrillation device and can be changed and adjusted to individual needs.
The range and limits of human TTI are of great interest for cardiac defibrillator testing and development. Therefore, the aim of this review is to determine the range of possible TTI in humans, the maximum and minimum TTI, in order to define the limits of patient impedance. In addition, TTI and its relationship to various influencing factors are examined in more detail, including the shock waveforms and different shock protocols, the coupling devices, electrode size and pressure, the placement of electrodes, patient age, gender, body dimensions, respiration and lung volume, the blood hemoglobin saturation and the impact of various pathologies.

2. Materials and Methods

This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement [6].

2.1. Data Sources and Search Strategies

Keywords were defined based on the aim of this review. The first two main keywords, KW1 = “transthoracic impedance” and KW2 = “defibrillation”, were combined for an initial search, and then a third keyword (KW3) related to specific characteristics was added, and the search was repeated. The databases NCBI (PubMed Central) and Google Scholar were searched with all keywords and their combinations shown in Figure 1.

2.2. Selection of Studies

For this systematic review, the relevant literature on TTI measurements and influencing factors between 1970 and 2021 was considered. Inclusion and exclusion criteria are summarized in Table 1. TTI measurements recorded for both defibrillation and cardioversion were included in this survey because both therapies treat patients with arrhythmias by delivering energy to the thorax. The only difference is that the shocks are synchronized with the QRS complex in cardioversion and are not so in defibrillation. The TTI is not affected by this difference. For a meta-analysis of human TTI additional criteria were defined (see also Table 1).
Figure 2 shows the systematic approach of literature identification, screening and inclusion. A total of 144 articles from database search and 28 articles from other methods were pre-selected for their relevance to the aim of the review using the abstracts of the papers. The aforementioned criteria (Table 1) formed the basis of paper selection. Citations were searched and reviewed using the bibliographies of the previously selected literature.
Articles deemed relevant were screened for eligibility, and the full text was carefully analyzed and categorized into different topic groups (TTI meta-analysis and review of the various TTI influencing factors) using RefWorks and Mendeley as reference management software. Finally, a total of n = 71 articles were included in this review.

2.3. Data Extraction and Analysis

The analysis of the data was divided into two parts:
  • Meta-analysis of all human TTI data with the aim of defining the range of possible TTI in humans including the maximum and minimum values of TTI;
  • A detailed analysis of TTI influencing factors with the aim of assessing the relevance of each influencing factor on TTI.
For the meta-analysis, all human impedance measurements collected from the selected literature were included in Table A1 along with the measurement details, which were selected based on the investigated influencing factors (i.e., patient age, gender, weight, electrode type and placement, etc). Because of the large differences in the recording of TTI in the different studies, the technical details of the measurements and data on arrhythmia of the patients were documented as well to better compare the data. In some studies, more than one series of measurements was performed and all recordings with different configurations were included. Basic statistical methods were used for statistical analysis. Impedance results are reported as mean ± SD in Ω . Matlab® (MathWorks) was used to create statistical plots for the presentation and analysis of the data.
The literature findings on different factors influencing TTI were reported, discussed qualitatively and compared for each influencing factor individually. Finally, an overall trend of how the factor alters TTI was given, along with a conclusion.

3. Results and Discussion

3.1. TTI an Ohmic Resistance

In various studies, the applied voltage and transversing current were recorded and virtually no phase difference could be detected [1,7,8]. This was found to be true for different waveforms, including damped sine wave and biphasic shocks. In terms of clinical defibrillation, resistance and impedance are equivalent. From these observations, it follows that TTI can be considered purely resistive according to Ohm’s Law [1].
The layer between the electrode and the body surface could act as a capacitor, but at the high current densities that occur during defibrillation, the capacitances are negligible [1].

3.2. Recording Methods for TTI

The recording of shock TTI values for research purposes is problematic for ethical reasons. It is not possible to apply high currents to healthy human hearts to record voltage and calculate the TTI. Only patients undergoing defibrillation or cardioversion can thus be monitored by modified defibrillators and a shock impedance at which the actual countershock can be recorded. This is, of course, easier for cardioversion because this procedure can be scheduled.
The other possibility is the estimation of the high-frequency impedance, which is measured before or without actual shock. This is a test-pulse method, where a weak current (generated by approximately 5 V at 20–30 kHz [9]) is passed through the thorax, and by applying fitting methods, the TTI can be predicted. The accuracy and validity of this method has been evaluated in different studies [9,10,11]. In some measurements of these studies, individual differences between test pulse and on shock impedances of 15–17% were found. However, since this was not the case for all measurements and a correlation coefficient of r = 0.986 was obtained between the test pulse impedance at 50 kHz and the actual shock impedance, the high-frequency measurements are sufficiently accurate to be considered and accepted as TTI in this analysis [8].
Table A1 in the Appendix A summarizes the different measurement methods as additional information to the TTI recordings.

3.3. Statistical Analysis of TTI Recordings

The mean TTI, maximum and minimum TTI (minimal, mean, maximal value and SD; not weighted to the number of subjects in the study) were calculated for the entire data set summarized in Table A1. The results are shown in Table 2.
In the following section, the statistical results summarized in Table 2 are discussed and references to Table A1 are provided. The documented measurements are numbered and for simplicity, No. # refers to the corresponding measurement in Table A1.

3.3.1. Analysis of Mean TTI Recordings

The maximum observed mean TTI was 162 Ω , which was measured by Bissing and Kerber (see No. 79) [9]. In this case, the TTI was recorded from hairy patients, and poor electrode/tissue coupling could explain the exceptionally high mean TTI. A high value of 148 Ω was reported by Samson et al. in a pediatric study (see No. 98) [12]. Such high impedance values in pediatric defibrillation are common and are also found in other pediatric measurements (see No. 90–99) because of the small electrodes. All other mean TTI values are below 112 Ω , resulting in an averaged mean TTI value of 77.8 Ω . This value is within the range of 70–80 Ω given as the average TTI value for adults in the American Heart Association (AHA) Guidelines [13].
The minimum mean TTI was found to be 36 Ω by Caterine et al. (see No. 59) [14]. These measurements were made with gel between the electrodes in the AA position. This explains the very low impedances caused by the low impedance path created by the gel smear. However, there is no guarantee that a patient will receive sufficient current to the myocardium under these circumstances. All other mean TTI values showed at least 49 Ω .
The mean TTI SD values across all studies ranged from 3–36 Ω . The highest SD value with paddles was measured by Kerber et al. [15]. The paddle pressure can significantly alter TTI (see Section 3.4.5) and could be the cause of the high SD value. The smallest TTI SD value of 3 Ω was measured by Bissing and Kerber (see No. 81) [9]. All patients in this study had similar characteristics in that they were all shaved, hairy males. Two different studies (see Nos. 82–89) that examined different hairy patients, and coupling agents also showed very small TTI SDs of 4.0–6.4 Ω . These observations suggest that using the same coupling minimizes the SD values of TTI SD, which is surprising with respect to hirsutism. Nevertheless, the influence of the electrode/tissue interface appears to be a dominant factor of TTI. The average TTI SD was 16.4 Ω , which again shows that impedance varies greatly due to all the different influencing factors.
The highest and lowest mean TTI were not recorded in many studies (n = 32). The lowest TTI was measured by Kerber et al. with 12 Ω (see No. 3) [15]. Maximum low values of 74 Ω were reported in pediatric TTI examinations of infants aged 6 weeks to 9 months (see No. 92), indicating that body measurements alone are not determinant of TTI. In this study, small electrodes were used, and TTI decreased to a normal range after the use of adult paddles. The size of the electrode seems to outweigh the influence of body size and weight. The highest TTI of 212 Ω (see No. 90) was documented in the same study by Atkins et al. [16].

3.3.2. Analysis of Adult TTI Data

Most of the extreme values discussed before have been attributed to pediatric measurements. However, the focus of this review is not on children and therefore pediatric data were excluded for the following histogram and boxplot representations. In addition, experiments on gel smears (Nos. 59 and 60), extremely hairy patients (No. 79) and without coupling gel (No. 89) were excluded because these measurement conditions represent extreme situations.
A mean average value of 76.7 Ω was calculated for the TTI in adults, which is 1.1 Ω smaller than the mean average value for the TTI including pediatric data. This is due to the high impedances caused by pediatric electrodes.
Figure 3 demonstrates the mean TTI characteristics of adults found in the literature, where the mean TTIs show almost normal distribution. The highest frequency of mean TTI is in the range of 73–80 Ω , which complies well with the median value given in the boxplots (75.0 Ω ) as shown in Figure 4.
The boxplot in Figure 4, as a second visual representation of the TTI data, complements and reinforces the histogram plots. The spectrum of 25th and 75th percentiles of mean TTI found in the literature ranges from approximately 67.1–83.5 Ω . The median value of 75.0 Ω (min 51 Ω , max 112 Ω ) is only slightly below the middle of the percentiles. The SD boxplot is evenly split, with a central median at 16.5 Ω .

3.4. Analysis of Influencing Factors

Further analysis of TTI in this review was narrowed down to a systematic view of the components that influence TTI. The different influencing factors found in the literature review are shown and categorized in Figure 5. This analysis also includes data from animal studies.
In the following sections, the 12 influencing factors are described and discussed in detail.

3.4.1. Influence of Waveforms

The influence of the shock waveforms applied by the defibrillator and the resulting effects on TTI are presented and discussed in this section.
In a randomized study with damped monophasic sine waves ( n = 77 ) and rectilinear biphasic shocks ( n = 88 ) conducted by Mittal et al., the mean TTI for biphasic shocks was 76 ± 17 Ω and 78 ± 16 Ω for the monophasic waveform. The rectilinear biphasic waveform was found to be beneficial in patients with high impedance because it was insensitive to changes in TTI [17].
Similar results were observed by Page et al. TTI was higher in patients treated with monophasic shocks in whom cardioversion had failed in at least one shock than in patients immediately converted to regular heart rhythm ( p = 0.02 ). No difference in TTI ( p = 0.94 ) was observed in biphasic patients [18].
In the study by Niemann et al., mono- and biphasic waveforms applied after 90 s vf were compared. Here, a marginally significant decrease in TTI ( p < 0.05 ) was observed with biphasic waveforms applied to pigs [19]. Although the cause of this change could be attributed to the waveform, further explanations were not possible.
It can be concluded that the biphasic waveform is less sensitive to changes in TTI. The greater defibrillation efficiency of the biphasic waveform could not be attributed to the decrease in TTI. Further studies are needed in this area to determine the influence of the waveform on TTI and the resulting effects.

3.4.2. Influence of Serial Shocks

As early as 1975, Pantridge et al. described the use of successive shocks when the first shock had failed. A decrease in impedance was thought to explain the success of repeated shocks with the same energy [20]. Nevertheless, the effect of repeated shocks on TTI remains controversial. While five studies support Pantridge et al. and the idea of a decrease in TTI [15,21,22,23,24], three other studies failed to confirm a change in TTI [11,25,26].
In the study by Kerber et al., the TTI was 52 ± 19 Ω at the initial shock and decreased to 48 ± 16 Ω ( p < 0.01 ) at the second shock. The changes in TTI were small and, according to the authors, not of clinical significance [15]. In a larger clinical study with n = 307 patients conducted by Walsh et al., a decrease in TTI with successive shocks was observed in both the AA and AP positions. The greatest decrease was noted between the first two shocks, with 4.3 ± 1.6 Ω in AA and 3.9 ± 4.5 Ω in AP positions [21]. However, a relatively high SD values raise concerns about the significance of the reduction and the overall impact of repeated shocks in TTI.
A small, but significant decrease in TTI of 2.7 % with each subsequent shock ( n = 37 ) was found in the study conducted by Deakin et al. This could be due to the inflammatory response of the human body to the electric-current-induced damage [22]. The observations by Sirna et al. of erythematous rings on the chest of patients after removal of the electrodes support this theory. Deakin et al. also suggested that ionization phenomena might affect TTI. The impedance decreases when the energy used for defibrillation is increased. This effect could accumulate with successive shocks. The results for monophasic and biphasic defibrillation were comparable in this study [22].
In a study conducted only one year later, in 2009, Fumagalli et al. were able to confirm the above results. Fluid changes were thought to be the cause of the TTI changes because inflammation may increase vascular permeability and thus reduce impedance. The authors considered plausible the possibility of using multiple shocks with the same energy to achieve more efficient results with less tissue damage [24].
A total of 863 records of automated external defibrillators for the effect of multiple shocks were examined by Walker et al., but the authors came to a very different conclusion. In most cases, impedance remained unchanged, and in almost as many cases, the impedance decreased ( n = 149 ) or even increased ( n = 124 ) after the first shock. Notably, shocks of the same energy resulted in only minimal changes in TTI [11]. The major difference of this study compared with previous ones is that data from outpatient cardiac arrests were analyzed. Although the AHA Guidelines recommend the use of stacked shocks [27], the authors disagree with this and suggest moving away from this technique [11].
Monophasic and biphasic waveforms were tested on a swine model by Niemann et al. Again, repeated shocks did not alter TTI for both waveforms [25]. In Koster et al. only a small increase in TTI from 103 ± 24 Ω to 106 ± 23 Ω was documented. Here, impedance was measured before each shock using a high-frequency, low-level signal [26].
The reviewed articles could not give a clear answer on the influence of stacked shocks on TTI. Several studies reported decreases rather than stable TTI. All observed decreases were small with a high SD, so the significance of these results remains questionable.

3.4.3. Influence of Coupling Devices

Different electrodes, pastes and gels have been developed and tested for use in order to optimize coupling of the electrodes with the body.
Using self-adhesive electrode pads, a TTI of 75 ± 21 Ω was measured by Kerber et al., which was slightly higher than with standard-size electrode paddles in comparable previous studies (67 ± 36 Ω ) [28]. Similar findings were reported by Deakin et al., where Hewlett Packard® self-adhesive pads, PhysioControl® paddles and Hewlett Packard® paddles were compared, and all three electrode types yielded similar TTI results (62.9 Ω , 64.7 Ω and 68.3 Ω ). Using the self-adhesive pads lead to slightly lower TTI values than the paddles. However, gel impedance was not recorded directly in this study [29].
Impedance was found to be significantly higher ( p < 0.0001 ) by Dodd et al. when electrode pads were used instead of paddles in AA and AP positions [30]. The reduction in TTI with paddles is probably mainly due to the higher force applied by the operator (see also Section 3.4.5). In addition, the surface area of the pads was 1 cm 2 smaller than that of the paddles (see Section 3.4.4). All these factors can accumulate and lead to the observed reduction.
Various gels and pastes are used for better contact during defibrillation. Redux paste was chosen as a coupling agent in a pediatric study conducted by Atkins et al. with significantly reduced TTI of 13 % ( p < 0.05 ) [16]. Consistent with this study, Sirna et al. also documented an increase in mean TTI of more than 100 % without the use of a coupling agent from 65 ± 5 Ω to 160 ± 5 Ω ( n = 37 , p < 0.01 ). However, this study was performed with paddles and not pads as in the previous study [23].
Two different electrode pads (Littman Defib® pads and Harco® pads) without an additional coupling layer and with Redux® paste (Hewlett-Packard) as a coupling gel were tested in dogs by Aylward et al. TTI was significantly lower with the Redux® paste compared to the two pads without paste (by approximately 12 Ω with p < 0.01 ) [31].
A human study by Caterine et al. examined TTI during gel smearing between two electrodes. A reduction of 38 % (58.0 ± 10.3 Ω to 36.0 ± 7.6 Ω ) was observed with smeared gel. The low impedance pathway created between the electrodes decreased the predicted transcardiac current ratio by 22 % . This problem could be anticipated and compensated for by apex-anterior positioning.
As concluded by Caterine et al., gel applications and smearing had the greatest effect on TTI [14].

3.4.4. Influence of Electrode Size

One of the first TTI studies was conducted by Geddes et al., where animals of different sizes where investigated. Larger electrodes were used for bigger animals to reduce the impedance and allow sufficient current to cross the thorax [32]. Several animal and human studies followed, and all consistently showed that increasing paddle or pad size reduced TTI [9,12,15,28,29,32,33,34].
A mean TTI of 112.2 ± 17.0 Ω for small self-adhesive electrocardiogram defibrillator pads with a diameter of 8 cm was measured in the study by Dalzell et al. For electrodes with 8 cm in apex and 12 cm parasternal position, a TTI of 92.3 ± 22.0 Ω was obtained. For both electrodes with a diameter of 12 cm, the TTI further decreased to 71.6 ± 14.0 Ω [33].
Comparable results were documented by Kerber et al. with 13 cm and 8.5 cm paddles and by Bissing and Kerber for different electrode areas of 192 cm2 and 164 cm2, respectively [9,15].
Electrode size as a factor influencing TTI is one of the most important issues in pediatric defibrillation. Pediatric electrodes have been developed to fit on the chest of children. These are much smaller and result in significantly higher TTI than adult electrodes ( p < 0.0001 ). Mean impedances of 148 ± 23 Ω were measured for pads with diameters of 4, 4.5 and 5.8 cm and only 49 ± 9 Ω for diameters of 8 and 10 cm [12]. A more detailed consideration of the influences of TTI in pediatric defibrillation can be found in Section 3.4.7.
It has been shown that TTI decreases with larger electrode diameter, which increases current flow and thus could improve the success rate of defibrillation. At the same time, however, the use of electrodes that are too large could cause the current to pass through the myocardial tissue by seeking other routes through the thorax [15]. This assumes that there is an optimal electrode size that allows for optimal transmyocardial current and, thus, the best defibrillation results [29,33]. Indeed, for a given electrode size, the intracardiac current is optimized for each individual. This was investigated by Hoyt et al. in a study of mongrel dogs [34].

3.4.5. Influence of Electrode Pressure

The force applied to electrodes significantly reduced TTI, as demonstrated in several studies [5,15,23,35,36,37,38,39,40].
A 25% reduction in TTI with firm paddle contact pressure compared to light paddle contact pressure was measured by Kerber et al. in a study with dogs. Contact at the electrode or skin surface is improved by increasing the number of low-resistance electrical contact points. In this study, Redux® paste was used as a coupling agent. Increased pressure could lead to a more homogeneous distribution of the contact paste and could thus also contribute to the reduction in TTI. Paddle pressure and paddle size were found to have an additive effect on TTI. A larger paddle size plus paddle pressure resulted in a 40% reduction in TTI [15].
These observations were confirmed by Sirna et al., who provided evidence from their data [23]. A similar human study was published by Deakin et al., where the paddles were placed anteroapically. TTI decreased exponentially with applied paddle force up to 12 kg, and 8 kgf was sufficiently high and physically achievable for 80% of defibrillator operators [35,36]. The reduction achieved with 8 kgf on the electrodes was due to improved skin contact and reduced lung volume from pressure on the thorax (see Section 3.4.10) [37].
In addition to the absolute force, the electrode size over which the force is distributed plays an important role in determining the TTI. For smaller electrodes, the force per unit area is higher than for larger electrodes applying the same force. For this reason, the pressure on the electrodes must also be considered with explicit reference to the size of the electrode area. Small electrodes are of greatest importance in pediatric defibrillation. In the study by Deakin et al., TTI was found to be optimally low when pediatric paddles (16 cm 2 ) with only 3 kgf are used for the defibrillation of infants weighing less than 10 kg. With adult paddles (82 cm 2 ), approximately 5 kgf is used for the defibrillation of children ≤10 kg (see Section 3.4.7) [5].
Not only the force on paddles but also the force applied to self-adhesive defibrillator pads can reduce TTI. This was observed in a study by Persse et al. in a swine model during countershock and by Cohen et al. in a study of active compression cardioversion in human [38,39]. Ramirez et al. also measured a significant reduction in TTI with pressure on the pads in the AL position but not in AP-positioned pads [36]. In a study by Sado et al., the paddle force even reduced the effect of hirsutism, which increases TTI. At 1 kgf, for example, the difference in the mean TTI between unshaved and shaved men was 13.2 Ω [40].
In summary, it can be said that increasing the electrode pressure is one of the most influential factors in reducing TTI. For adult defibrillation with electrode paddles, 8 kgf is recommended [35,37].

3.4.6. Influence of Electrode Position

To clarify the influence of the electrode position on the TTI, the positions and their abbreviations are clearly defined in Figure 6.
Different AA positions, the apex-to-anterior (AA1) and parasternal-to-anterior position (AA2), were compared by Caterine et al., and almost the same TTI of 58.0 ± 10.3 Ω and 51.0 ± 10.9 Ω , respectively, was measured [14]. Another fact to consider when positioning both electrodes in anterior positions is the gel smearing that may occur between the two electrodes. This could create a low-resistance pathway, as described in Section 3.4.3.
A study by Deakin et al. examined the longitudinal and transversal placement of the apex rectangular paddle in AA1 positioning. For all paddle forces less than 12 kgf, a higher TTI was measured in the transverse position. The above observation is confirmed when paddle force is also considered. The difference in TTI was greatest at low paddle forces and decreased at high paddle forces [41]. Very similar TTI values for different anterior–posterior (AP) measurements were found by Garcia and Kerber. Apex-right infrascapular (AP1) yielded 76.8 ± 18.4 Ω , apex-left infrascapular (AP2) 72.1 ± 18.7 Ω , anterior-right infrascapular (AP3) 72.5 ± 19.4 Ω and anterior-left infrascapular (AP4) 71.6 ± 18.6 Ω mean TTI [42]. Interestingly, TTI does not differ in the posterior positions either.
Most of the studies reviewed compared different AA and AP placements. The data on AA and AP positions are compared in Table 3. From there, we gather that there is a tendency for AA positioning to yield a slightly higher TTI than AP positioning. Similar observations can be made with respect to the AL position relative to the AP position. A meta-analysis by Zhang et al. of 10 randomized clinical trials involving n = 1281 patients concluded that TTI was higher in the AL group than in the AP group, confirming the above results [43].
In summary, TTI was lower in the AP position than in the AA and AL electrode positions, although in some studies this was not sufficient to be significant. Most authors agree that despite slight differences, pad positioning is not a critical determinant of TTI [21,42,44,45,46,47,48].

3.4.7. Influence of Age

Since human physiognomy changes with age, it was hypothesized that TTI could be influenced by these changes.
Pediatric electrodes have been developed for defibrillation in children. These electrodes are smaller in diameter than adult electrodes. This results in higher impedance and reduces peak current output by up to 25% [49].
TTI was measured by Samson et al. in children with electrodes of different sizes (4 to 10 cm diameter) covered by pre-gelled stannous chloride pads. For diameters of 4, 4.5 and 5.8 cm, the mean TTI was 148 ± 23 Ω , compared with 49 ± 9 Ω for diameters of 8 and 10 cm [12]. It is noticeable that the TTI recorded using the smallest electrodes is twice as high as the value of 76.7 Ω measured in adults, demonstrating that the influence of electrode size is more dominant than the age-related changes of the body. For older children, larger electrodes can be used, taking arcing into account [49]. For children older than one year, electrodes with a diameter of 7 cm were recommended [12]. This is consistent with the findings of Atkins et al., who observed that TTI was reduced by 47% when adult electrodes (83 cm 2 ) were used instead of pediatric paddles (21 cm 2 ) [16].
In the study by Samson et al., it was found that children’s TTIs were higher than expected based on their weight and body measurements alone. The recommendation of 2 J k g shock energy may need to be reconsidered based on the TTI analysis and increased accordingly [50]. TTI decreased less with applied force when pediatric paddles were used, as demonstrated by Deakin et al. The use of adult paddles for children up to 8 years of age resulted in a maximum reduction in TTI of 39.4% with paddle force and for children from 9 to 17 years of age, in a maximum reduction of 26.3% [5].
Significant differences in TTI as a function of age ( p < 0.01 ) was found by Garcia and Kerber. TTI was higher with age in three electrode positions (anterior-apex, anterior-posterior and apex-posterior). Impedance measurements also correlated with the BSA. To exclusively examine the effect of age on TTI, measurements were divided into two groups with BSA < 1.8 m 2 and >1.8 m 2 ( p > 0.001 ). For both groups, TTI increased with age, as shown in Table 4.
The authors suggested that the increase in TTI could be due to body posture in age, with pathological symptoms such as kyphoscoliosis. This could lengthen the path between electrodes, leading to higher TTI [42]. In contrast, Fumagalli et al. found that age had no effect on TTI. However, this result can be explained by the fact that 75% of patients were older than 69 years [2].
There are major differences between pediatric and adult defibrillation. The use of the electrodes, the optimal paddle force, energy matching and serial shocks must be considered and adapted to the needs of children. Generalization is difficult because of the very different characteristics of children at different ages and developmental stages. Even though one study found TTI to be generally higher with age [42], literature regarding a correlation of age and TTI was too scarce and sample sizes too small to draw any meaningful conclusions on this behalf.

3.4.8. Influence of Gender

The results regarding the relationship between TTI and gender were controversial, and no clear trend was found. The effects of sex-typical characteristics on TTI such as hairiness, pregnancy and placement of electrodes on the chest were investigated and are presented below.
In the study by Caterine et al., the TTI was recorded for males and females in different application scenarios, showing that the impedance was lower for females without gel smear (see Table 5). These differences in the results for males and females could be due to the different distribution of subcutaneous tissue in the sexes. The placement of electrodes on the female breast was avoided [14].
A higher TTI in women than in men was measured by Fumagalli et al. A total of 80 patients (45% women) were studied using 78 cm 2 self-adhesive defibrillator pads, with TTI measured after the first shock. Using electrical impedance tomography, forearm conductivity was measured higher in male subjects. These results were attributed to the different structure of adipose tissue between the sexes and to the statistically higher fat increase in women with age. Estrogen-dependent modulations in tissue may also be important for TTI when comparing the sexes [2]. This explanation was confirmed by Roh et al., denoting a higher mean TTI in women than in men (77 ± 15 Ω ) vs. 63 ± 11 Ω , p < 0.001 ) [51]. Three further studies by Garcia and Kerber, Koster et al. and Dalzell and Adgey found no significant difference between the sexes in TTI [26,42,52].
Chest pilosity is more common in men than in women and is therefore regarded as a feature to be considered as a possible influencing factor for male patients. Krasteva et al. concluded that TTI was slightly higher ( p > 0.05 ) when measured in men with pilosity due to poorer skin contact [48].
Furthermore, Bissing and Kerber compared male subjects who were shaved and unshaved, and reported a 35% decrease in mean TTI after shaving. In addition, hairy versus non-hairy patients yielded a significantly lower mean TTI (59 Ω , p < 0.01 ) for the patients without pilosity. In this study, exceptionally high mean TTI values were documented for hairy patients, suggesting that shaving before defibrillation is necessary to ensure adequate electrode contact, especially in patients with severe hairiness [9]. The discrepancy between the two studies in terms of hairiness may be due to the difficulty in determining the degree of hirsutism. A third study by Sado et al. attempted to address this issue by defining the hair mass in grams. A regression analysis was performed, demonstrating a decrease in TTI after shaving as a function of hair mass [40].
In the study by Nanson et al., TTI was recorded before and after a pregnancy. Mean impedance was 91.3 ± 15.8 Ω within 2 weeks before anticipated delivery and 91.6 ± 11.8 Ω 6–8 weeks after delivery, when physiological status had normalized. Despite significant physiological changes, such as an increase in total body water of 6–8 liters and a 40–50% increase in blood volume, measurements on n = 45 women showed that impedance remained unchanged [53].
Another characteristic that must be considered in women is the positioning of the electrodes directly on the female breast. TTI was measured by Pagan-Carlo et al. by placing the apex electrode on the breast, below and lateral to the breast. The mean TTIs were reported to be 95 ± 25 Ω , 84 ± 17 Ω and 83 ± 20 Ω , respectively. Positioning directly on the breast resulted in a significantly higher TTI (by 14% with p < 0.01 ) than in the other two positions. In the large-breasted group with a higher brassiere size was the increase even greater (at 16%) [54].
A tendency for TTI to correlate with gender is difficult to discern because of the inconsistency of results in different studies. This could lead to the conclusion that gender does not affect TTI in general, but further studies are needed to confirm this. However, characteristic differences between the sexes (pilosity and the female breast) would need to be investigated on a case-by-case basis.

3.4.9. Influence of Body Dimensions and Mass

The relationship between body measurements and TTI was not as readily apparent in the various studies as expected. The measurement and classification of the body mass required definition. Different indicators such as weight, chest size, BSA and BMI were used in the different studies, making a comparison difficult.
A study by Page et al. with n = 203 subjects found that patients in whom initial shock cardioversion failed had a higher TTI of 83 ± 16 Ω vs. 71 ± 19 Ω ( p = 0.0007 ), which correlated with a higher weight of 93 ± 23 kg vs. 80 ± 17 kg [18]. From reports such as this, the debate arises about how much energy should be applied during defibrillation of severely obese patients. If energy needs to be adjusted upward, an impact of weight on TTI is implied.
A statistically significant but small relation between body weight and TTI was documented by Deakin et al. In this study n = 80 children aged 10 weeks to 17 years were examined. Using adult paddles for children of less than 10 kg weight, a significant relation was found at 5.0 kgf paddle force ( p < 0.0001 ). The authors note that this relationship is not significant enough to be of clinical relevance [5].
Another major change in body weight can be observed during pregnancy. Nanson et al. found that TTI was unchanged before and after child delivery. The mean TTI of all participants was 81.6 Ω at birth and 70.5 Ω after delivery [53]. The lack of detailed patient data unfortunately limits the conclusions that can be drawn from the study. Another problem is the use of ’weight’ as a determinant of body mass. By merely measuring the weight of the patients, no information is given about the constitution of the body. Body mass relevant to the defibrillation process may not correlate with weight at all, as is evident in pregnancy. Overall, additional body fluids in the abdomen and the fetus account for the additional weight and therefore do not affect TTI during defibrillation.
This suggests the use of a different body parameter. In the study by Kerber et al., the influence of chest width and body weight on TTI was investigated. TTI was found to be weakly correlated with weight and more strongly correlated with chest width. Different paddle sizes were used, and a weak correlation with weight was found only for the standard size paddles ( r = 0.45 , p < 0.05 ) [15]. The effects of paddle size changes on TTI must be of greater influence on TTI, so that the minimal influence of weight is not significant. Of all body measures considered in this study, TTI correlated most strongly with chest width [15].
Chest size and weight were also measured in a study by Krasteva et al. The mean weight of the patients ( n = 86 ) was 75.9 ± 15.1 kg and the chest circumference was 103.4 ± 10.7 cm (range 86 to 130 cm). A weak correlation ( r < 0.5 , p < 0.05 ) between both parameters and TTI was found [48].
Another commonly used body characteristic is the BMI. A direct relationship between TTI and BMI was found in four studies [2,42,51,55]. In a bivariate, age-adjusted analysis with n = 80 patients, a linear increase with r = 0.574 and p = 0.001 was found [2]. Wan et al. confirmed the positive correlation of TTI with BMI ( r = 0.33 , p < 0.01 , n = 623 ) using a wearable cardioverter-defibrillator [55]. A multivariate logistic regression analysis came to the same conclusion (B = 1.598, p < 0.001 ). The authors of this study explain the increase in TTI by adipose tissue [51]. In the study by Garcia and Kerber, the BSA ranged from 1.4–3.0 m 2 (mean 2.2 ± 0.9 m2), and a linear relationship was found ( r = 0.55 , p < 0.001 ). The authors conclude that increasing distance between the electrodes must increase TTI directly [42].
Overall, the studies reviewed show little, if any, rise in TTI with increasing body dimensions. The difficulty of using meaningful body characteristics and the wide range of influencing factors on TTI make a reliable analysis very difficult. In contrast to the hypothesis, the influence of body dimensions seems to be small. Nonetheless, research in the field of defibrillation of severely obese patients needs to continue to ensure that successful defibrillation is accessible to all.

3.4.10. Influence of Respiration and Lung Volume

Lung volume has been found to increase TTI in seven studies [23,36,37,56,57,58,59].
In the study by Sirna et al. a 9% lower mean TTI was observed during end-expiration compared to end-inspiration (50 ± 3 Ω vs. 55 ± 3 Ω ) [23]. In another study, the onset of expiration coincides with the maximum drop in the ventilation TTI curve [59]. These results were confirmed by Deakin et al., where higher lung volumes appear to result in longer current paths, leading to greater TTI [56].
High PEEP was found to additionally increase TTI in a linear relationship. For example, in the study by Deakin et al., a PEEP of 20 cm H2O increased TTI by 6%. At high PEEP levels, the change in TTI can be substantial [56].
The relationship between lung volume and paddle force was also investigated by Deakin et al. Fixed lung volume and variable lung volume tests were performed. It was found that TTI was higher in the fixed lung volume group for all measured paddle forces. The effect of lung volume was greatest at approximately 2 kgf of paddle force. Beyond 2 kgf , the decrease in TTI from baseline with increasing paddle force was dominated by the electrical contact between the paddle and skin. Only 16% of the total decrease in TTI could be attributed to changes in lung volume [37].
A different aspect on lung volume changes was investigated by Kim et al. In this study TTI was measured during various body positions and activities. TTI was affected by vital capacity in the upright, stationary position. In the supine position, an increase in TTI was found with decreasing end-inspiratory volume. This was not expected by the authors and was not consistent with the previous results presented above. A possible explanation could be that other factors (mechanical and/or physiological) dominate the influence on TTI. When TTI was examined during exercise, impedance was found to remain unchanged during the end-inspiratory increase in lung volume. These findings were unexpected and may again be due to other factors [57].
Different gas compositions and their influence on TTI were investigated in another study by Deakin et al. A total of 10 patients were tested with breathing air, 100% O2, 30% O2 + 70% N2O and 30% O2 + 70% He. No significant differences in TTI were found. Because of the lower conductivity of gases compared with tissue, it is likely that the current paths around the gas volumes in the lungs pass through blood and tissues. This explains the unchanged TTI results for different gas compositions in the lungs [58].
In summary, full lung volume may lead to a slight increase in TTI in humans, but it is not a major determinant of TTI. To compensate for influences of respiration, TTI measurements can be made at end-expiratory time points. Greater stability of TTI with respiratory changes was reported by Ramirez et al. in subjects with high BMI [36].

3.4.11. Influence of Blood Hemoglobin Saturation

The authors of three different studies agreed that Hb O 2 saturation is directly proportional to TTI [2,24,60].
Using multivariate linear regression analysis, Fumagalli et al. found that an increase of 1 g d l raised TTI by 1.9 ± 0.6 Ω ( p = 0.004 ) [2]. This change in impedance can be attributed to the electrical properties of the blood, which are affected by Hb concentration. It is believed that plasma is the conductive property, and the erythrocytes change the viscosity. It is also thought that endothelial cells and red blood cells serve as an insulating layer around the capillary wall [2]. These and other observations may explain the relationship between TTI and Hb saturation.
An even smaller increase in TTI of 0.2 ± 0.1 Ω was also found by Fumagalli et al. ( p = 0.0392 ). A bivariate linear regression model was used to obtain the slope of TTI versus Hb O 2 saturation [24]. An increase in TTI was seen in all ( n = 222 ) but five patients. Higher saturation was generally associated with higher TTI change. In this study, 9.5 % of the patients were diagnosed with COPD. COPD leads to a reduction in muscle mass, increasing the proportion of adipose tissue. In addition, lung tissue appears less vascularized. This resulted in higher TTI compared to the other patients. The effect of Hb O 2 saturation on TTI may be partially related to COPD and the increase in TTI associated with COPD symptoms [24].
A decrease in Hb O 2 saturation may be caused by hypoxia, in which a part of tissue is insufficiently oxygenated. In an animal study by Wojtczak, it was found that cytoplasmic resistance can be affected by different ion concentrations after prolonged hypoxia. The main reason for the change in internal longitudinal resistance was found to be an increase in impedance at intercellular junctions [60].
It can be concluded that higher Hb O 2 saturation results in a small increase in TTI. The influence of Hb O 2 saturation is likely to be of clinical interest only in combination with pathological symptoms, providing atypical Hb O 2 saturation values.

3.4.12. Influences of Pathologies

Several pathologies were found to influence TTI outcomes. Pulmonary edema, hypothermia, sternotomy, CHF and COPD are reviewed in the following section for their effects on TTI .
In a study by Fein et al., TTI measurements were performed for n = 27 normal subjects and 33 patients of 2 groups of pulmonary edema of different severity. The TTI of patients without edema and with moderate edema were very similarly distributed and hardly distinguishable from each other. A decrease in TTI of at least 5% correlated directly with radiographic evidence of severe pulmonary edema. The increase in fluid in the tissues and lungs increases conductivity and thus decreases resistance [61]. This is consistent with the findings of Peacock et al., where a significant decrease ( p < 0.0002 ) in TTI was found for patients with cardiomegaly or abnormal pulmonary fluid [62].
The aim of both studies was to predict pulmonary edema, and therefore, the setup was somewhat different from the measurements for defibrillation. In the experiment by Fein et al., a constant alternating current was applied with two electrodes, and the voltage drop was recorded with two others to calculate impedance [61]. In the second study, the IQ monitor from Renaissance Technology, Inc., was used to collect TTI data [62]. Nevertheless, the results can be applied to TTI during defibrillation, and lower TTI values can be expected in severe pulmonary edema.
The measurement of TTI during induced hypothermia in human patients is ethically problematic due to the undesirable side effects of greatly reduced body temperature. For this reason, transferable animal experiments in pigs and dogs were carried out.
In the study by Rhee et al., severe hypothermia (down to 30 °C) was found to facilitate defibrillation because of altered myocardial properties. Often, improved shock success can be attributed to higher peak currents, resulting from lower resistance. Unexpectedly, the TTI results were slightly higher ( p < 0.0001 ) in severe hypothermia than in normothermia [63]. These findings are confirmed by Savino et al., who found a significant increase ( p < 0.05 ) in TTI under hypothermic conditions in 22 mongrel dogs, 14 of which were hypothermic with a mean central venous temperature of 27 °C. The mean difference in TTI between the 2 groups was only 3 Ω [64]. Note that metabolic demand, energy demand and oxygen consumption are reduced during hypothermia, and all these changes could explain the effect on TTI [63].
Sternotomy is a major surgical intervention into the mediastinum. Kerber et al. reported that this surgical procedure greatly reduces TTI ( p < 0.01 ), with changes persisting after wound healing. The changes were most prominent in the apex-right parasternal and left parasternal-right infrascapular position and less pronounced in the lateral-lateral position, where the current path does not cross the incision path [46].
During wound healing, tissue edema, inflammation, pleural effusions and hyperemia are common body responses. The increase in blood and extracellular fluids results in improved current conduction and thus decreased resistance. Long-term decreased TTI is thought to be due to scarring and adhesions that alter the properties of tissue [46].
In a clinical study with n = 222 subjects conducted by Fumagalli et al., 9.5 % of them diagnosed with COPD showed a lower reduction in TTI with successive shocks compared with the other patients ( p = 0.033 ). COPD alters body characteristics by reducing muscular mass, increasing adipose tissue and decreasing vascularized lung tissue, which could be the reason for the reduction in TTI [24].
Increased thoracic water content in patients with congestive heart failure (CHF) could also explain a reduced TTI. In the study by Fumagalli et al., a bivariate, age-adjusted analysis was performed, which showed a mean reduction of 5.3 ± 2.0 Ω with statistical significance ( p = 0.009 ) [2].
Several (patho)physiological factors can affect conductance and thus TTI, especially when parts in the thorax are affected. The more advanced the disease, the greater the changes that affect TTI. In some pathologies, such as pulmonary edema, TTI has even been studied as a possible indicator for diagnostic purposes.

3.5. Summary of Influencing Factors and Clinical Consequences

All influencing factors found in the literature review are summarized in Table 6.
The factors are categorized in low, medium and high influence on TTI. In addition, a brief summary of the conclusiveness of the categorization based on the detailed analysis and discussion of the influencing factors in Section 3.4 is provided.
From a clinical point of view, we can conclude that the most influential factors on TTI were the coupling device, electrode size and electrode pressure. In this context, the most important parameters to reduce TTI and thus improve the defibrillation success rate are increasing the electrode pressure and applying the gel correctly to achieve optimal conductivity between the electrode and the skin. Although the tissue between the electrodes accounts for most of the impedance, the coupling at the electrode/tissue interface is thus responsible for the largest changes in TTI. Furthermore, larger electrode diameter increases current flow as expected, but electrodes that are too large could cause the current to not pass through the myocardial tissue optimally. For a given energy setting of the defibrillator, a too high TTI in turn reduces current flow and may impair the ability of the electrical shocks to defibrillate, whereas a biphasic shock waveform is less sensitive to changes in TTI in general. There is also a major difference between defibrillation in children and adults. Reduced electrode size and optimal paddle force, energy matching and serial shocks must be considered and adapted to the needs of children. No clear trend was found in the influence of gender, but little increase in TTI was observed with increasing body dimensions, especially with chest width. This may require adjustments to electrode configurations and energy settings. A full lung volume, however, may lead to a slight increase in TTI, but is not a major determinant of TTI. To compensate for influences of respiration, it is recommended that defibrillation be performed at the end of expiration to further reduce TTI. Pathophysiological factors such as changes in tissue composition, pulmonary edema, sternotomy and others may affect conductance and thus TTI and should be considered during defibrillation when possible in an emergency situation.

4. Conclusions

The transthoracic impedance (TTI) is a major determinant of the transthoracic current flow and must be controlled during cardiac defibrillation to increase the success rate of defibrillation. In this systematic review, we analyzed the range and limits of the TTI studied and reviewed 12 different factors influencing this parameter. The major finding of the meta-analysis was that the TTI in humans ranges between 12 and 212 Ω in the reviewed literature, also including pediatric TTI data. This range is even wider than previously expected. However, the mean TTI values range from 51 to 112 Ω when the outliers and pediatric measurements are excluded. From these data showing normal distribution, a mean TTI of 76.7 Ω (median 75.0 Ω ) was calculated, confirming the mean TTI of an adult human, which is between 70 and 80 Ω , as stated in the American Heart Association (AHA) Guidelines [13].
The large number of influencing factors demonstrates the complexity to analyze TTI. In order to filter out a specific influencing factor, all other factors would have to be kept stable, which is not always possible. Many studies also lack detailed information (see Table A1), which somewhat limited the analysis of the data.

Author Contributions

Conceptualization, Y.H. and C.B.; methodology, Y.H.; validation, C.B.; formal analysis, Y.H.; investigation, Y.H.; data curation, C.B.; writing—original draft preparation, Y.H. and C.B.; writing—review and editing, Y.H., C.B. and D.B.; visualization, Y.H.; supervision, C.B.; All authors have read and agreed to the published version of the manuscript.

Funding

Open Access Funding by the Graz University of Technology.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank Jürgen Rack for his guidance and proofreading of the first draft of the literature review. His ideas, support and expertise were greatly appreciated. This work was supported by TU Graz Open Access Publishing Fund.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

The following abbreviations are used in this manuscript:
TTItransthoracic impedance
SDstandard deviation
Hbhemoglobin
AAanterior-anterior
ALanterior-lateral
APanterior-posterior
vfventricular fibrillation
vtventricular tachycardia
vaventricular arrhythmia
afatrial fibrillation
aaatrial arrhythmia
BSAbody surface area
PEEPpositive end-expiratory pressure
BMIbody mass index
CHFcongestive heart failure
COPDchronic obstructive pulmonary disease

Appendix A

Table A1. TTI measurements from the literature research. Measurements performed in a study and their results are associated with the different measurement configurations.
Table A1. TTI measurements from the literature research. Measurements performed in a study and their results are associated with the different measurement configurations.
No.SourcesTTI in ΩYearPatientsAge in YearsWeight in kgElectrodesCurrentWaveformTTI Measurement DetailsArrythmiaAdditional Information
MeanSDLowestHighestnFemaleMaleMeanSDMeanSDArea in cm2TypePositionin kHz
1[15]60.0031.0015.00143.00198144----72-57paddlesAL-damped sinosoidcalculationvf-
267.0036.0016.00143.00198121------133paddlesAL-damped sinosoidcalculationvf-
353.0024.0012.00132.00198123------57paddlesAL-damped sinosoidcalculationvf-
4[65]90.0023.0027.00152.002005102----------biphasiccalculationvf, vt-
5[66]75.0021.0028.00150.001988347-------paddles/pads--damped sinosoidmonitored by a microprocessorvf, vt, af-
6[4]65.0014.0046.0085.00199010285520--60padsAL--calculation--
7[48]107.2022.3058.00152.0020068649395714761592padsAL32.00-high-frequency impedancenone-
896.6019.2055.00149.0020068649395714761592padsAP32.00-high-frequency impedancenone-
9[52]93.003.0038.00137.001991702050665--50/113padsAA30.00-high-frequency impedancevf-
10[33]112.0017.00--1989105317464---50padsAA30.00-high-frequency impedancevf-
1192.3022.00--198963--64---50/113padsAA30.00-high-frequency impedancevf-
1271.6014.00--198934--64---113padsAA30.00-high-frequency impedancevf-
13[47]77.5018.40--199945--6610--106padsAA18.00-calculationaf-
1473.7018.40--199945--6610--106padsAP18.00-calculationaf-
1575.6018.5043.00133.0019999030606610--106padsAA or AP18.00-calculationafduring first shock
1668.8015.40--19999030606610--106padsAA or AP18.00-calculationafduring last shock
17[54]95.0025.00--19962525---8522-paddlesAA31.25square wavehigh-frequency impedance-on breast
1884.0017.00--19962525---8522-paddlesAA31.25square wavehigh-frequency impedance-under breast
1983.0020.00--19962525---8522-paddlesAA31.25square wavehigh-frequency impedance-lateral to breast
20[67]78.1019.4028.00118.00198419-------paddles-31.00-high-frequency impedancevf, vt, af-
21[68]74.0029.00--1996100------57/113paddles/padsAA or AP-damped sinosoidfirst shock impedancevf, vt-
22[10]69.9014.0041.00100.0019894073362---113padsAA30.00-high-frequency impedancevf, aapre-gelled
2365.1015.9038.0097.00198941122963---113padsAA30.00-high-frequency impedancevfpre-gelled
24[8]--55.00125.00200115--599811365paddles-50.00biphasichigh-frequency impedanceaf-
25[28]75.0021.0028.00150.00198468------50/113padsAA or AP---vt,vf, af-
2679.0026.00--198468------50/113padsAA---vt,vf, af-
2773.0016.00--198468------50/113padsAP---vt,vf, af-
28[46]77.0018.00--199217-------paddlesAA31.25square wavehigh-frequency impedancenonewithout sternotomy
2959.0017.00--199217-------paddlesAA31.25square wavehigh-frequency impedancenonewith sternotomy
30[42]82.0024.70--19982010104218--78padsAA31.25square wavehigh-frequency impedancenone-
3171.2023.50--19982010104218--78padsAP31.25square wavehigh-frequency impedancenone-
3277.0024.70--19982010104218--78padsAP31.25square wavehigh-frequency impedancenone-
33[41]81.4813.34--200320713----90paddlesAA (trans.)--modified defibrillator-at end-expiration with 6 kg force
3477.5813.25--200320713----90paddlesAA (long.)--modified defibrillator-at end-expiration with 6 kg force
35[37]70.501.00--200435728----85paddlesAA--using Labview (National Instruments)-on gel pads, with variable lung volume
3672.251.00--200435728----85paddlesAA--using Labview (National Instruments)-on gel pads, with fixed lung volume
37[22]92.20-52.00126.00200858124668-85--padsAA-biphasicfirst shock impedanceaf-
38[11]86.00-73.00103.002009467-------pads--biphasicshock impedancevf-
39[56]65.706.90--1998126630----padsAA30.00damped sinosoidBodystat MultiScan 5000noneat end-expiration
40[29]68.2016.10--19984004032---82paddlesAA30.00damped sinosoidBodystat MultiScan 5000noneat end-expiration
4162.8013.20--19984004033---99paddlesAA30.00damped sinosoidBodystat MultiScan 5000noneat end-expiration
4264.6014.30--19984004034---85paddlesAA30.00damped sinosoidBodystat MultiScan 5000noneat end-expiration
4395.6022.30--19984004035---64paddlesAA30.00damped sinosoidBodystat MultiScan 5000noneat end-expiration
44[53]91.3015.8063.00137.7020014545032-82--padsAA30.00monophasicBodystat MultiScan 5000none2 weeks before estimated date of delivery
4591.6011.5069.30118.3020014242032-71--padsAA30.00monophasicBodystat MultiScan 5000none6–8 weeks after delivery
46[24]57.7011.40--2009222731497311751378padsAP5.00biphasiccalculationaffirst shock
4754.1010.80--2009222731497311751378padsAP5.00biphasiccalculationaflast shock
48[18]91.0013.00--2002107347365138824167card. electrodesAP-monophasicshock impedanceaffailed cardioversion in ≤4 shocks
4979.0019.00--2002107347365138824167card. electrodesAP-monophasicshock impedanceafno failed cardioversion
5076.006.00--200296276965148719167card. electrodesAP-biphasicshock impedanceaffailed cardioversion in ≤4 shocks
5176.0018.00--200296276965148719167card. electrodesAP-biphasicshock impedanceafno failed cardioversion
52[26]104.0027.00--2008467893786314---paddles--biphasichigh-frequency impedancevfall
53109.0027.00--200889890-----paddles--biphasichigh-frequency impedancevfonly women
54103.0027.00--20083780378-----paddles--bipasichigh-frequency impedancevfonly men
55104.0026.00--2008467893786314---paddles--biphasichigh-frequency impedancevf1991 successful shocks
56102.0022.00--2008467893786314---paddles--biphasichigh-frequency impedancevf536 failed shocks
57[14]58.0010.30--19971055-----paddlesAA31.25square wavehigh-frequency impedancenone-
5851.0010.90--19971055-----paddlesAA31.25square wavehigh-frequency impedancenone-
5936.007.60--19971055-----paddlesAA31.25square wavehigh-frequency impedancenonewith gel smear
6051.008.00--19971055-----paddlesAA31.25square wavehigh-frequency impedancenonewith gel smear
61[2]57.7012.3037.0089.002006802555739741378padsAP5.00biphasicshock impedanceaf-
62[44]73.8016.80--2003311120591568115-padsAL-damped sinosoidmodified Hewlett-Packard defibrillatoraf-
6365.5014.50--200339122758106716-padsAP-damped sinosoidmodified Hewlett-Packard defibrillatoraf-
64[17]78.0016.0041.00124.0019998829596512892178/113gel padsAP-biphasicshock impedanceaf-
6576.0017.0040.00112.0019997721566612932478/113gel padsAP-damped sinosoidshock impedanceaf-
66[21]90.0021.00--200515055956710---padsAA-biphasicshock impedanceaf-
6785.0018.00--2005157571006614---padsAP-biphasicshock impedanceaf-
68[45]69.3016.0039.00131.00199080314962---50/113padsAP or AA30.00--af-
6966.7016.00--199057------50/113padsAP30.00--af-
7075.4013.00--199023------50/113padsAA30.00--af-
71[58]59.208.10--19981028-----padsAA30.00sinosoidhigh-frequency impedancenoneAir
7260.407.90--19991028-----padsAA30.00sinosoidhigh-frequency impedancenone100% O2
7360.607.80--20001028-----padsAA30.00sinosoidhigh-frequency impedancenone30% O2 + 70% N2O
7460.008.80--20011028-----padsAA30.00sinosoidhigh-frequency impedancenone30% O 2 + 70% Helium
75[30]75.8014.10--20042171470-80-82paddlesAA30.00sinosoidhigh-frequency impedanceaf-
7692.6016.99--20042171470-80-80padsAA30.00sinosoidhigh-frequency impedanceaf-
7766.5013.90--20042171470-80-82paddlesAP30.00sinosoidhigh-frequency impedanceaf-
7892.1023.30--20042171470-80-80padsAP30.00sinosoidhigh-frequency impedanceaf-
79[9]162.0011.00--2000909----164 or 192padsAA31.25square wavehigh-frequency impedancenonehirsute patients
80103.006.00--20001156----164 or 192padsAA31.25square wavehigh-frequency impedancenonenon -hirsute patients
81105.003.00--2000909----164 or 192padsAA31.25square wavehigh-frequency impedancenoneshaved hirsute group
82[40]78.506.40--200315------143paddlesAA--modified defibrillatornonehirsute patients at 8 kgf
8371.505.40--200315------143paddlesAA--modified defibrillatornonehirsute patients at 8 kgf, after shaving
8473.204.90--200325------143paddlesAA--modified defibrillatornonenon -hirsute patients at 8 kgf
8572.505.10--200325------143paddlesAA--modified defibrillatornonenon -hirsute patients at 8 kgf, after shaving
8665.104.80--200310------143paddlesAA--modified defibrillatornonenon -hirsute patients at 8 kgf, control group
87[23]54.004.00--198837-------padsAA31.24square wavehigh-frequency impedanceaa, va, nonesalt-containing coupling agent
8865.005.00--198837-------padsAA31.24square wavehigh-frequency impedanceaa, va, nonesalt-free coupling agent
89160.0018.00--198837-------padsAA31.24square wavehigh-frequency impedanceaa, va, noneno coupling agent
90[16]108.0024.0061.00212.00198837------21paddles---high-frequency impedancenonepediatric data, children 1.5–15 years
9157.0011.0029.00101.00198837------83paddles---high-frequency impedancenonepediatric data, children 1.5–15 years
9294.0017.0074.00124.00198810------21paddles---high-frequency impedancenonepediatric data, infants 6 weeks to 9 months
93[69]56.8023.4027.7094.502010532145477-padsAA-biphasic-cardiac arrestpediatric data, 0.1 pre-shock and post-shock
9455.2022.2028.3093.102010532145477-padsAA-biphasic-cardiac arrestpediatric data, 0.1 s post-shock baseline
95[5]106.80---200312--1-7-16paddlesAA--using Labview (National Instruments)-pediatric data, on gel pads
9653.30---200368--3-16-85paddlesAA--using Labview (National Instruments)-pediatric data, on gel pads
9769.30---200368--13-44-85paddlesAA--using Labview (National Instruments)-pediatric data, on gel pads
98[12]148.0023.00--199524--4361613padsAA31.00square wavehigh-frequency impedancenonepediatric data
9949.009.00--19959--43--79padsAA31.00square wavehigh-frequency impedancenonepediatric data
100[70]73.6020.7026.00146.002017593----------biphasicPhilips HeartStart XL/ HeartStart MRx defibrillatorsatrial fibrillationfirst shock TTI
10176.6022.6026.00146.002017110----------biphasicPhilips HeartStart XL/ HeartStart MRx defibrillatorsatrial flutterfirst shock TTI
102[71]74.0018.00--201850012937166119524----biphasicLIFEPAK 20e/ HeartStart XLaffirst shock TTI
10374.0018.00--201850012937166119524----biphasicLIFEPAK 20e/ HeartStart XLafmaximum
10470.0016.00--201838910028966119625-paddles/padsAP-biphasicLIFEPAK 20e/ HeartStart XLafUsing OAFCP, first shock TTI
10571.0016.00--201838910028966119625-paddles/padsAP/AL-biphasicLIFEPAK 20e/ HeartStart XLafUsing OAFCP, maximum
106[72]79.004.4073.0084.0020205055411---paddlesAL-biphasicStandard direct-current ecaf-
107[51]64.0011.00--2021466903766011---padsAP-biphasicHeartStart MRx, after energy deliveryaf, at, aa-
10863.0011.00--20213760376-----padsAP-biphasicHeartStart MRx, after energy deliveryaf, at, aamale
10977.0015.00--202190900-----padsAP-biphasicHeartStart MRx, after energy deliveryaf, at, aafemale
110[73]78.0021.4032.00154.0020179219736417---pads-20.00biphasiccalculated (LIFEPAK 12)vfno return of spontaneous circulation
11173.8020.4032.00154.00201710533726314---pads-20.00biphasiccalculated (LIFEPAK 12)vfreturn of spontaneous circulation
112[36]81.4017.6--201611011-----padsAL--calibrated impedance circuitnoneshaved hirsute, at rest
11385.6016.50--201611011-----padsAL--calibrated impedance circuitnoneshaved hirsute, at inspiration
11479.6019.20--201611011-----padsAL--calibrated impedance circuitnoneshaved hirsute, at end-expiration
11574.9017.30--201611011-----padsAL--calibrated impedance circuitnoneshaved hirsute, applied force (6-15 kgf)
11670.9016.6--201611011-----padsAP--calibrated impedance circuitnoneshaved hirsute, at rest
11773.9016.20--201611011-----padsAP--calibrated impedance circuitnoneshaved hirsute, at inspiration
11870.0016.40--201611011-----padsAP--calibrated impedance circuitnoneshaved hirsute, at end-expiration
11967.1014.80--201611011-----padsAP--calibrated impedance circuitnoneshaved hirsute, applied force (6–15 kgf)
Table explanations: ‘-’ stands for missing data; Electrode areas are given as first electrode/second electrode; card. electrode = cardioversion electrode; energy is given in min-max energy; none = no defibrillation shock and/or arrhythmia; defi. = defibrillation; AA, AL, AP, vf, vt, af, va, aa see abbreviations.

References

  1. KenKnight, B.H.; Eyuboglu, B.M.; Ideker, R.E. Impedance to defibrillation countershock: Does an optimal impedance exist? PACE-Pacing Clin. Electrophysiol. 1995, 18, 2068–2087. [Google Scholar] [CrossRef] [PubMed]
  2. Fumagalli, S.; Boni, N.; Padeletti, M.; Gori, F.; Boncinelli, L.; Valoti, P.; Baldasseroni, S.; Bari, M.D.; Masotti, G.; Padeletti, L.; et al. Determinants of Thoracic Electrical Impedance in External Electrical Cardioversion of Atrial Fibrillation. Am. J. Cardiol. 2006, 98, 82–87. [Google Scholar] [CrossRef] [PubMed]
  3. Sado, D.M. How good is your defibrillation technique? J. R. Soc. Med. 2005, 98, 3–6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Lerman, B.B.; Deale, O.C. Relation Between Transcardiac and Transthoracic Current During Defibrillation in Humans. Circ. Res. 1990, 67, 1420–1426. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Deakin, C.D.; Bennetts, S.H.; Petley, G.W.; Clewlow, F. What is the optimal paddle force during paediatric external defibrillation? Resuscitation 2003, 59, 83–88. [Google Scholar] [CrossRef]
  6. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372. [Google Scholar] [CrossRef]
  7. Hatib, F.A.; Trendafilova, E.; Daskalov, I. Transthoracic electrical impedance during external defibrillation: Comparison of measured and modelled waveforms. Physiol. Meas. 2000, 21, 145. [Google Scholar] [CrossRef]
  8. Krasteva, V.; Hatib, F.A.; Trendafilova, E.; Daskalov, I. Possibilities for predictive measurement of the transthoracic impedance in defibrillation. J. Med. Eng. Technol. 2001, 25, 195–200. [Google Scholar] [CrossRef] [PubMed]
  9. Bissing, J.W.; Kerber, R.E. Effect of shaving the chest of hirsute subjects on transthoracic impedance to self-adhesive defibrillation electrode pads. Am. J. Cardiol. 2000, 86, 587–589. [Google Scholar] [CrossRef]
  10. Dalzell, G.W.; Cunningham, S.R.; Anderson, J.; Adgey, A.A. Initial experience with a microprocessor controlled current based defibrillator. Heart 1989, 61, 502–505. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Walker, R.G.; Koster, R.W.; Sun, C.; Moffat, G.; Barger, J.; Dodson, P.P.; Chapman, F.W. Defibrillation probability and impedance change between shocks during resuscitation from out-of-hospital cardiac arrest. Resuscitation 2009, 80, 773–777. [Google Scholar] [CrossRef]
  12. Samson, R.A.; Atkins, D.L.; Kerber, R.E. Optimal size of self-adhesive preapplied electrode pads in pediatric defibrillation. Am. J. Cardiol. 1995, 75, 544–545. [Google Scholar] [CrossRef]
  13. Link, M.S.; Atkins, D.L.; Passman, R.S.; Halperin, H.R.; Samson, R.A.; White, R.D.; Cudnik, M.T.; Berg, M.D.; Kudenchuk, P.J.; Kerber, R.E. Part 6: Electrical therapies: Automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010, 122, S706–S719. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Caterine, M.R.; Yoerger, D.M.; Spencer, K.T.; Miller, S.G.; Kerber, R.E. Effect of Electrode Position and Gel-Application Technique on Predicted Transcardiac Current During Transthoracic Defibrillation. Ann. Emerg. Med. 1997, 29, 588–595. [Google Scholar] [CrossRef]
  15. Kerber, R.E.; Grayzel, J.; Hoyt, R.; Marcus, M.; Kennedy, J. Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation 1981, 63, 676–682. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Atkins, D.L.; Sirna, S.; Kieso, R. Pediatric defibrillation: Importance of paddle size in determining transthoracic impedance. J. Crit. Care 1989, 4, 319. [Google Scholar] [CrossRef]
  17. Mittal, S.; Ayati, S.; Stein, K.M.; Schwartzman, D.; Cavlovich, D.; Tchou, P.J.; Markowitz, S.M.; Slotwiner, D.J.; Scheiner, M.A.; Lerman, B.B. Transthoracic cardioversion of atrial fibrillation: Comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000, 101, 1282–1287. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Page, R.L.; Kerber, R.E.; Russell, J.K.; Trouton, T.; Waktare, J.; Gallik, D.; Olgin, J.E.; Ricard, P.; Dalzell, G.W.; Reddy, R.; et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: The results of an international randomized, double-blind multicenter trial. J. Am. Coll. Cardiol. 2002, 39, 1956–1963. [Google Scholar] [CrossRef] [Green Version]
  19. Niemann, J.T.; Burian, D.; Garner, D.; Lewis, R.J. Transthoracic monophasic and biphasic defibrillation in a swine model: A comparison of efficacy, ST segment changes, and postshock hemodynamics. Resuscitation 2000, 47, 51–58. [Google Scholar] [CrossRef]
  20. Pantridge, J.F.; Adgey, A.A.J.; Webb, S.W.; Anderson, J. Electrical Requirements For Ventricular Defibrillation. Br. Med. J. 1975, 2, 313–315. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Walsh, S.; McCarty, D.; McClelland, A.; Owens, C.; Trouton, T.; Harbinson, M.; O’Mullan, S.; McAllister, A.; McClements, B.; Stevenson, M.; et al. Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: A multi-centre comparison of antero-apical and antero-posterior pad positions. Eur. Heart J. 2005, 26, 1298–1302. [Google Scholar] [CrossRef] [PubMed]
  22. Deakin, C.D.; Ambler, J.J.S.; Shaw, S. Changes in transthoracic impedance during sequential biphasic defibrillation. Resuscitation 2008, 78, 141–145. [Google Scholar] [CrossRef] [PubMed]
  23. Sirna, S.J.; Sirna, S.J.; Ferguson, D.W.; Ferguson, D.W.; Charbonnier, F.; Charbonnier, F.; Kerber, R.E.; Kerber, R.E. Factors affecting transthoracic impedance during electrical cardioversion. Am. J. Cardiol. 1988, 62, 1048–1052. [Google Scholar] [CrossRef]
  24. Fumagalli, S.; Tarantini, F.; Caldi, F.; Makhanian, Y.; Padeletti, M.; Boncinelli, L.; Valoti, P.; Serio, C.D.; Pellerito, S.; Padeletti, L.; et al. Multiple shocks affect thoracic electrical impedance during external cardioversion of atrial fibrillation. PACE-Pacing Clin. Electrophysiol. 2009, 32, 371–377. [Google Scholar] [CrossRef]
  25. Niemann, J.T.; Garner, D.; Lewis, R.J. Transthoracic impedance does not decrease with rapidly repeated countershocks in a swine cardiac arrest model. Resuscitation 2003, 56, 91–95. [Google Scholar] [CrossRef]
  26. Koster, R.W.; Walker, R.G.; Chapman, F.W. Recurrent ventricular fibrillation during advanced life support care of patients with prehospital cardiac arrest. Resuscitation 2008, 78, 252–257. [Google Scholar] [CrossRef]
  27. Callaway, C.W.; Donnino, M.W.; Fink, E.L.; Geocadin, R.G.; Golan, E.; Kern, K.B.; Leary, M.; Meurer, W.J.; Peberdy, M.A.; Thompson, T.M.; et al. Part 8: Post–Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015, 132, S465–S482. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Kerber, R.E.; Martins, J.B.; Kelly, K.J.; Ferguson, D.W.; Kouba, C.; Jensen, S.R.; Newman, B.; Parke, J.D.; Kieso, R.; Melton, J. Self-adhesive preapplied electrode pads for defibrillation and cardioversion. J. Am. Coll. Cardiol. 1984, 3, 815. [Google Scholar] [CrossRef] [Green Version]
  29. Deakin, C.D.; McLaren, R.M.; Petley, G.W.; Clewlow, F.; Dalrymple-Hay, M.J.R. A comparison of transthoracic impedance using standard defibrillation paddles and self-adhesive defibrillation pads. Resuscitation 1998, 39, 43–46. [Google Scholar] [CrossRef]
  30. Dodd, T.E.L.; Deakin, C.D.; Petley, G.W.; Clewlow, F. External defibrillation in the left lateral position—A comparison of manual paddles with self-adhesive pads. Resuscitation 2004, 63, 283–286. [Google Scholar] [CrossRef] [PubMed]
  31. Aylward, P.E.; Kieso, R.; Hite, P.; Charbonnier, F.; Kerber, R.E. Defibrillator electrode-chest wall coupling agents: Influence on transthoracic impedance and shock success. J. Am. Coll. Cardiol. 1985, 6, 682–686. [Google Scholar] [CrossRef] [Green Version]
  32. Geddes, L.A.; Tacker, W.A.; Rosborough, J.P.; Moore, A.G.; Cabler, P.S. Electrical dose for ventricular defibrillation of large and small animals using precordial electrodes. J. Clin. Investig. 1974, 53, 310–319. [Google Scholar] [CrossRef] [Green Version]
  33. Dalzell, G.W.N.; Cunningham, S.R.; Anderson, J.; Adgey, A.A.J. Electrode pad size, transthoracic impedance and success of external ventricular defibrillation. Am. J. Cardiol. 1989, 64, 741–744. [Google Scholar] [CrossRef]
  34. Hoyt, R.; Grayzel, J.; Kerber, R.E. Determinants of intracardiac current in defibrillation. Experimental studies in dogs. Circulation 1981, 64, 818–823. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Deakin, C.D.; Sado, D.M.; Petley, G.W.; Clewlow, F. Determining the optimal paddle force for external defibrillation. Am. J. Cardiol. 2002, 90, 812–813. [Google Scholar] [CrossRef]
  36. Ramirez, F.D.; Fiset, S.L.; Cleland, M.J.; Zakutney, T.J.; Nery, P.B.; Nair, G.M.; Redpath, C.J.; Sadek, M.M.; Birnie, D.H. Effect of Applying Force to Self-Adhesive Electrodes on Transthoracic Impedance: Implications for Electrical Cardioversion. PACE-Pacing Clin. Electrophysiol. 2016, 39, 1141–1147. [Google Scholar] [CrossRef] [PubMed]
  37. Deakin, C.D.; Sado, D.M.; Petley, G.W.; Clewlow, F. Differential contribution of skin impedance and thoracic volume to transthoracic impedance during external defibrillation. Resuscitation 2004, 60, 171–174. [Google Scholar] [CrossRef] [PubMed]
  38. Persse, D.E.; Dzwonczyk, R.; Brown, C.G. Effect of Application of Force to Self-Adhesive Defibrillator Pads on Transthoracic Electrical Impedance and Countershock Success. Ann. Emerg. Med. 1999, 34, 129–133. [Google Scholar] [CrossRef]
  39. Cohen, T.J.; Ibrahim, B.; Denier, D.; Haji, A.; Quan, W. Active compression cardioversion for refractory atrial fibrillation. Am. J. Cardiol. 1997, 80, 354–355. [Google Scholar] [CrossRef]
  40. Sado, D.M.; Deakin, C.D.; Petley, G.W.; Clewlow, F. Comparison of the effects of removal of chest hair with not doing so before external defibrillation on transthoracic impedance. Am. J. Cardiol. 2004, 93, 98–100. [Google Scholar] [CrossRef] [PubMed]
  41. Deakin, C.D.; Sado, D.M.; Petley, G.W.; Clewlow, F. Is the orientation of the apical defibrillation paddle of importance during manual external defibrillation? Resuscitation 2003, 56, 15–18. [Google Scholar] [CrossRef]
  42. Garcia, L.A.; Kerber, R.E. Transthoracic defibrillation: Does electrode adhesive pad position alter transthoracic impedance? Resuscitation 1998, 37, 139–143. [Google Scholar] [CrossRef]
  43. Zhang, B.; Li, X.; Shen, D.; Zhen, Y.; Tao, A.; Zhang, G. Anterior-posterior versus anterior-lateral electrode position for external electrical cardioversion of atrial fibrillation: A meta-analysis of randomized controlled trials. Arch. Cardiovasc. Dis. 2014, 107, 280–290. [Google Scholar] [CrossRef] [Green Version]
  44. Chen, C.J.; Guo, G.B.F. External Cardioversion in Patients With Persistent Atrial Fibrillation A Reappraisal of the Effects of Electrode Pad Position and Transthoracic Impedance on Cardioversion Success. Jpn. Heart J. 2003, 44, 921–932. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Dalzell, G.; Anderson, J.; Adgey, A. Factors Determining Success and Energy Requirements for Cardioversion of Atrial Fibrillation: Revised Version. QJM Int. J. Med. 1991, 78, 85–95. [Google Scholar] [CrossRef]
  46. Kerber, R.E.; Vance, S.; Schomer, S.J.; Mariano, D.J.; Charbonnier, F. Transthoracic defibrillation: Effect of sternotomy on chest impedance. J. Am. Coll. Cardiol. 1992, 20, 94–97. [Google Scholar] [CrossRef] [Green Version]
  47. Mathew, T.P.; Moore, A.; McIntyre, M.; Harbinson, M.T.; Campbell, N.P.S.; Adgey, A.A.J.; Dalzell, G.W.N. Randomised comparison of electrode positions for cardioversion of atrial fibrillation. Heart 1999, 81, 576–579. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Krasteva, V.; Matveev, M.; Mudrov, N.; Prokopova, R. Transthoracic impedance study with large self-adhesive electrodes in two conventional positions for defibrillation. Physiol. Meas. 2006, 27, 1009–1022. [Google Scholar] [CrossRef] [PubMed]
  49. Atkins, D.L.; Kerber, R.E. Pediatric defibrillation: Current flow is improved by using ’adult’ electrode paddles. Pediatrics 1994, 94, 90–93. [Google Scholar] [CrossRef]
  50. Samson, R.A.; Berg, R.A.; Bingham, R.; Biarent, D.; Coovadia, A.; Hazinski, M.F.; Hickey, R.W.; Nadkarni, V.; Nichol, G.; Tibballs, J.; et al. Use of automated external defibrillators for children: An update: An advisory statement from the Pediatric Advanced Life Support Task Force, International Liaison committee on resuscitation. Circulation 2003, 107, 3250–3255. [Google Scholar] [CrossRef] [Green Version]
  51. Roh, S.Y.; Ahn, J.; Lee, K.N.; Baek, Y.S.; Kim, D.H.; Lee, D.I.; Shim, J.; Choi, J.I.; Kim, Y.H. The impact of personal thoracic impedance on electrical cardioversion in patients with atrial arrhythmias. Medicina 2021, 57, 618. [Google Scholar] [CrossRef] [PubMed]
  52. Dalzell, G.W.; Adgey, A.A. Determinants of successful transthoracic defibrillation and outcome in ventricular fibrillation. Heart 1991, 65, 311–316. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Nanson, J.; Elcock, D.; Williams, M.; Deakin, C.D. Do physiological changes in pregnancy change defibrillation energy requirements? Br. J. Anaesth. 2001, 87, 237–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Pagan-Carlo, L.A.; Spencer, K.T.; Robertson, C.E.; Dengler, A.; Birkett, C.; Kerber, R.E. Transthoracic defibrillation: Importance of avoiding electrode placement directly on the female breast. J. Am. Coll. Cardiol. 1996, 27, 449–452. [Google Scholar] [CrossRef] [Green Version]
  55. Wan, C.; Szymkiewicz, S.J.; Klein, H.U. The impact of body mass index on the wearable cardioverter defibrillator shock efficacy and patient wear time. Am. Heart J. 2017, 186. [Google Scholar] [CrossRef] [PubMed]
  56. Deakin, C.D.; McLaren, R.M.; Petley, G.W.; Clewlow, F.; Dalrymple-Hay, M.J.R. Effects of positive end-expiratory pressure on transthoracic impedance—Implications for defibrillation. Resuscitation 1998, 37, 9–12. [Google Scholar] [CrossRef]
  57. Kim, C.; Fuglestad, M.; Richert, M.; Shen, W.; Johnson, B. Influence of lung volume, fluid and capillary recruitment during positional changes and exercise on thoracic impedance in heart failure. Respir. Physiol. Neurobiol. 2014, 202, 75–81. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Deakin, C.D.; McLaren, R.M.; Pack, L.S.; Petley, G.W.; Clewlow, F.; Dalrymple-Hay, M.J.R. Effects of respiratory gas composition on transthoracic impedance. Resuscitation 1998, 38, 193–195. [Google Scholar] [CrossRef]
  59. Berve, P.O.; Irusta, U.; Kramer-Johansen, J.; Skålhegg, T.; Kongsgård, H.W.; Brunborg, C.; Aramendi, E.; Wik, L. Transthoracic impedance measured with defibrillator pads—New interpretations of signal change induced by ventilations. J. Clin. Med. 2019, 8, 724. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Wojtczak, J. Contractures and Increase in Internal Longitudinal Resistance of Cow Ventricular Muscle Induced by Hypoxia. Circ. Res. 1979, 44, 88–95. [Google Scholar] [CrossRef] [Green Version]
  61. Fein, A.; Grossman, R.F.; Jones, J.G.; Goodman, P.C.; Murray, J.F. Evaluation of transthoracic electrical impedance in the diagnosis of pulmonary edema. Circulation 1979, 60, 1156–1160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Peacock, W.F.; Albert, N.M.; White, R.D.; Emerman, C.L. Bioimpedance Monitoring: Better Than Chest X-Ray for Predicting Abnormal Pulmonary Fluid? Congest. Heart Fail. 2000, 6, 86–89. [Google Scholar] [CrossRef] [PubMed]
  63. Rhee, B.; Zhang, Y.; Boddicker, K.; Davies, L.; Kerber, R. Effect of hypothermia on transthoracic defibrillation in a swine model. Resuscitation 2005, 65, 79–85. [Google Scholar] [CrossRef] [PubMed]
  64. Savino, G.V.; Ruiz, E.D.V.; Valentinuzzi, M.E. Transventricular Impedance during Fibrillation. IEEE Trans. Biomed. Eng. 1983, BME-30, 364–367. [Google Scholar] [CrossRef] [PubMed]
  65. White, R.D.; Blackwell, T.H.; Russell, J.K.; Snyder, D.E.; Jorgenson, D.B. Transthoracic impedance does not affect defibrillation, resuscitation or survival in patients with out-of-hospital cardiac arrest treated with a non-escalating biphasic waveform defibrillator. Resuscitation 2005, 64, 63–69. [Google Scholar] [CrossRef] [PubMed]
  66. Kerber, R.E.; Martins, J.B.; Kienzle, M.G.; Constantin, L.; Olshansky, B.; Hopson, R.; Charbonnier, F. Energy, current, and success in defibrillation and cardioversion: Clinical studies using an automated impedance-based method of energy adjustment. Circulation 1988, 77, 1038–1046. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Kerber, R.E.; Kouba, C.; Martins, J.; Kelly, K.; Low, R.; Hoyt, R.; Ferguson, D.; Bailey, L.; Bennett, P.; Charbonnier, F. Advance prediction of transthoracic impedance in human defibrillation and cardioversion: Importance of impedance in determining the success of low-energy shocks. Circulation 1984, 70, 303–308. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Kerber, R.E.; Kieso, R.A.; Kienzle, M.G.; Olshansky, B.; Waldo, A.L.; Carlson, M.D.; Wilber, D.J.; Aschoff, A.M.; Birger, S.; Charbonnier, F. Current-based transthoracic defibrillation. Am. J. Cardiol. 1996, 78, 1113–1118. [Google Scholar] [CrossRef]
  69. Niles, D.E.; Nishisaki, A.; Sutton, R.M.; Brunner, S.; Stavland, M.; Mahadevaiah, S.; Meaney, P.A.; Maltese, M.R.; Berg, R.A.; Nadkarni, V.M. Analysis of transthoracic impedance during real cardiac arrest defibrillation attempts in older children and adolescents: Are stacked-shocks appropriate? Resuscitation 2010, 81, 1540–1543. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Sadek, M.M.; Chaugai, V.; Cleland, M.J.; Zakutney, T.J.; Birnie, D.H.; Ramirez, F.D. Association between transthoracic impedance and electrical cardioversion success with biphasic defibrillators: An analysis of 1055 shocks for atrial fibrillation and flutter. Clin. Cardiol. 2018, 41, 666–670. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Ramirez, F.D.; Sadek, M.M.; Boileau, I.; Cleland, M.; Nery, P.B.; Nair, G.M.; Redpath, C.J.; Green, M.S.; Davis, D.R.; Charron, K.; et al. Evaluation of a novel cardioversion intervention for atrial fibrillation: The Ottawa AF cardioversion protocol. Europace 2019, 21, 708–715. [Google Scholar] [CrossRef] [PubMed]
  72. Velázquez-Rodríguez, E.; Pérez-Sandoval, H.A.; Rangel-Rojo, F.J. Orthogonal electrical cardioversion in atrial fibrillation refractory to biphasic shocks: A case series. Eur. Heart J.-Case Rep. 2020, 4, 1–5. [Google Scholar] [CrossRef] [PubMed]
  73. Anantharaman, V.; Wan, P.W.; Tay, S.Y.; Manning, P.G.; Lim, S.H.; Chua, S.J.T.; Mohan, T.; Rabind, A.C.; Vidya, S.; Hao, Y. Role of peak current in conversion of patients with ventricular fibrillation. Singap. Med. J. 2017, 58, 432–437. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Keyword combinations which were used for the literature search.
Figure 1. Keyword combinations which were used for the literature search.
Sensors 22 02808 g001
Figure 2. PRISMA 2020 flow diagram for updated systematic reviews which included searches of databases and other sources. See Page et al., 2021 [6]. For more information, visit: http://www.prisma-statement.org/ (accessed on 15 February 2022 ) [6].
Figure 2. PRISMA 2020 flow diagram for updated systematic reviews which included searches of databases and other sources. See Page et al., 2021 [6]. For more information, visit: http://www.prisma-statement.org/ (accessed on 15 February 2022 ) [6].
Sensors 22 02808 g002
Figure 3. TTI data from Table A1 shown as histograms. In each subgraph, the number of trials used for histogram analysis is denoted by ‘n’.
Figure 3. TTI data from Table A1 shown as histograms. In each subgraph, the number of trials used for histogram analysis is denoted by ‘n’.
Sensors 22 02808 g003
Figure 4. TTI data from Table A1 shown as boxplots. In each subgraph, the number of trials used for box plot analysis is denoted by ‘n’ below the graphs. The red line in the box indicates the median value. The upper and lower box boundaries represent the 25th and 75th percentiles, respectively. The most extreme data points are represented by the whiskers, excluding outliers. The latter are marked by a ‘+’ symbol.
Figure 4. TTI data from Table A1 shown as boxplots. In each subgraph, the number of trials used for box plot analysis is denoted by ‘n’ below the graphs. The red line in the box indicates the median value. The upper and lower box boundaries represent the 25th and 75th percentiles, respectively. The most extreme data points are represented by the whiskers, excluding outliers. The latter are marked by a ‘+’ symbol.
Sensors 22 02808 g004
Figure 5. All TTI influencing factors found in the literature review and categorization into the different impedance determining components.
Figure 5. All TTI influencing factors found in the literature review and categorization into the different impedance determining components.
Sensors 22 02808 g005
Figure 6. Positioning of the electrodes: AP positions (blue), AA positions (green) and AL positions (orange) each consist of two electrodes. The exact placement is indicated by the numbers and colors. For further reference, the additional abbreviations (AP1, AP2, etc.) are used in the text.
Figure 6. Positioning of the electrodes: AP positions (blue), AA positions (green) and AL positions (orange) each consist of two electrodes. The exact placement is indicated by the numbers and colors. For further reference, the additional abbreviations (AP1, AP2, etc.) are used in the text.
Sensors 22 02808 g006
Table 1. Inclusion and exclusion criteria for the analysis of TTI influencing factors and meta-analysis of human TTI measurements.
Table 1. Inclusion and exclusion criteria for the analysis of TTI influencing factors and meta-analysis of human TTI measurements.
Exclusion CriteriaInclusion Criteria
Reported OutcomesNo mention of TTIHuman and animal TTI measurements and analysis of factors influencing TTI
Exposure of InterestTTI without connection to defibrillationDefibrillation and cardioversion
Implanted device-based methodsElectrode and paddle TTI measurements
Relationship between tidal volume and TTI amplitude
Transthoracic impedance cardiography
SettingImpedance tracking in real timeOutpatient and inpatient hospital reports
DatePapers published before 1970Papers published 1970–2021
LanguageNon-EnglishEnglish
Additional criteria for meta-analysis of human TTI measurementsAnimal measurementsHuman TTI measurements only
Crucial data missing (mean, highest and lowest)Documentation of at least mean, highest or lowest TTI
Case studiesMinimum of 5 subjects
Table 2. Statistical analysis of mean TTI, maximum and minimum TTI of all collected data.
Table 2. Statistical analysis of mean TTI, maximum and minimum TTI of all collected data.
Statistical CalculationTTI in Ω
MinimumMeanMaximumSD
Mean TTI41.077.8127.816.4
Maximum TTI74.0162.0212.036.0
Minimum TTI12.036.084.03.0
sample size (n)3211832100
Table 3. Different AA vs. AP TTI measurements: A comparison of the literature. The symbol AP without specification was denoted when no further information on AP position was available.
Table 3. Different AA vs. AP TTI measurements: A comparison of the literature. The symbol AP without specification was denoted when no further information on AP position was available.
LiteratureAA/AL PlacementAP PlacementTTI in AA Position
Mean(± SD) in Ω
Mean TTI in AP Position
Mean (± SD) in Ω
n for AAn for AP
[44]AA1AP 73.8 ± 16.8 65.5 ± 14.5 3139
[45]AA1AP 75.4 ± 13 66.7 ± 16 2357
[42]AA1AP1 82.09 ± 24.6 71.29 ± 23.5 2020
[46]AA3AP5 77 ± 18 72 ± 20 1717
[47]AAAP 77.5 ± 18.4 73.7 ± 18.7 4545
[21]AA1AP4 90 ± 21 85 ± 18 150157
[48]ALAP2 107.2 ± 22.3 96.6 ± 19.2 8686
[30]AA1AP6 92.6 ± 16.99 92.1 ± 23.3 2121
[30]AA1AP6 75.8 ± 14.1 66.5 ± 13.9 2121
[36]ALAP 81.4 ± 17.6 70.9 ± 16.6 1111
Table 4. TTI mean ± SD ( Ω ) in relation to age (in years) and BSA (in m 2 ) with n = 20 [42].
Table 4. TTI mean ± SD ( Ω ) in relation to age (in years) and BSA (in m 2 ) with n = 20 [42].
TTIAge ≤ 42Age > 42
BSA < 1.8 55.3 ± 9.0 86.6 ± 13.7
BSA > 1.8 64.2 ± 19.6 93.1 ± 21.9
Table 5. Mean ± SD ( Ω ) of TTI at rest under different conditions determined by electrode position and gel application techniques in men ( n = 5 ) and women ( n = 5 ) [14].
Table 5. Mean ± SD ( Ω ) of TTI at rest under different conditions determined by electrode position and gel application techniques in men ( n = 5 ) and women ( n = 5 ) [14].
Electrode PositionGel Application TechniqueMale Mean TTI ± SD ( Ω )Female Mean TTI ± SD ( Ω )
Apex-to-anteriorPaddles only 65 ± 9.3 54 ± 4.0
Parasternal-to-anteriorPaddles only 55 ± 8.8 47 ± 6.3
Parasternal-to-anteriorSmeared 32 ± 4.3 40 ± 4.9
Apex-to-anteriorSmeared 54 ± 6.8 48 ± 3.6
Table 6. Factors influencing TTI found from the literature research are categorized according to the degree of influence (low, medium and high). An increase (↑) or decrease (↓) in TTI is represented by the respective symbol.
Table 6. Factors influencing TTI found from the literature research are categorized according to the degree of influence (low, medium and high). An increase (↑) or decrease (↓) in TTI is represented by the respective symbol.
FactorsSectionInfluenceChange of TTIConclusion
WaveformsSection 3.4.1lowno changeThe biphasic waveform was found to be less sensitive to changes in TTI. The reduction in TTI for the biphasic waveform compared to the monophasic waveform was minimal.
Serial shocksSection 3.4.2low↓ with shocksNot all studies are congruent. More studies reported decrease rather than stable TTI. All recorded decreases were small and SD usually high.
Coupling deviceSection 3.4.3high↓ for good couplingCorrect coupling (with gels/pastes and mechanical coupling of electrodes) at the electrode/tissue layer is a crucial factor for the TTI.
Electrode sizeSection 3.4.4high↓ with electrode sizeAll studies are congruent. Of particular significance in pediatric defibrillation with very small electrodes.
Electrode pressureSection 3.4.5high↓ with pressureAll studies are congruent. For adult defibrillation with paddles, 8 kgf is recommended.
Electrode positionSection 3.4.6medium↓ in APOverall, the TTI was lower in the AP position than in the AA and AL electrode positions (marginal in some studies). The TTI did not differ in the subgroups of the different AA positions nor in the AP positions. A  higher TTI was found for the transverse position compared to the longitudinal position.
AgeSection 3.4.7medium↑ with ageMost of the differences are between adults and children, mainly because of body measurements that change with age. Only one study found TTI generally higher with age.
GenderSection 3.4.8lowThe results are inconsistent and no trends given. Characteristic differences between sexes can be considered: Breast hair should be removed to allow adequate coupling, on breast positioning of electrodes increases TTI, pregnancy does not affect TTI.
Body dimensionsSection 3.4.9medium↑ with body dimensionsDifferent indicators were used in the different studies: weight, chest size, BSA and BMI, making comparison difficult. A small, if any, increase in TTI with increasing body dimensions is indicated. Severely overweight should be considered.
Respiration and lung volumeSection 3.4.10low↑ with lung volumeFull lung volume may result in a slight increase in TTI. Measurements can be taken at end-expiratory time points to fully compensate for the of respiration.
Hemoglobin saturationSection 3.4.11low↑ with Hb O2 saturationThree studies are congruent: Higher Hb O2 saturation has a slightly increasing effect on TTI. Only of clinical interest in combination with pathological symptoms leading to very atypical Hb O2 saturation values.
PathologiesSection 3.4.12lowMainly minor changes of TTI with pathological symptoms were observed. Severe changes were only documented after sternotomy. In general, the more advanced the pathophysiological symptoms, the greater the change in TTI.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Heyer, Y.; Baumgartner, D.; Baumgartner, C. A Systematic Review of the Transthoracic Impedance during Cardiac Defibrillation. Sensors 2022, 22, 2808. https://doi.org/10.3390/s22072808

AMA Style

Heyer Y, Baumgartner D, Baumgartner C. A Systematic Review of the Transthoracic Impedance during Cardiac Defibrillation. Sensors. 2022; 22(7):2808. https://doi.org/10.3390/s22072808

Chicago/Turabian Style

Heyer, Yasmine, Daniela Baumgartner, and Christian Baumgartner. 2022. "A Systematic Review of the Transthoracic Impedance during Cardiac Defibrillation" Sensors 22, no. 7: 2808. https://doi.org/10.3390/s22072808

APA Style

Heyer, Y., Baumgartner, D., & Baumgartner, C. (2022). A Systematic Review of the Transthoracic Impedance during Cardiac Defibrillation. Sensors, 22(7), 2808. https://doi.org/10.3390/s22072808

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop